John Tavis

15PUBLICATIONS
22CO-AUTHORS
Biologically active moleculesRespiratory diseasesCheminformatics and quantitative structure-activity relationshipsPreventative health careMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 06, 2025
Correction for Woodson et al., "Efficacy and in vitro pharmacological assessment of novel N-hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitors".

Molly E Woodson, Holly F Walden, M Abdul Mottaleb

|Oct 29, 2025
Discovery of N-Hydroxypyridinedione-Based Inhibitors of HBV RNase H: Design, Synthesis, and Extended SAR Studies.

Dea Chotzalli, Vasiliki Pardali, Holly M Walden

|Feb 10, 2025
Discovery of bimodal hepatitis B virus ribonuclease H and capsid assembly inhibitors.

Daniel P Bradley, Caleb J Valkner, Qilan Li

|Nov 27, 2024
Efficacy and in vitro pharmacological assessment of novel N-hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitors.

Molly E Woodson, Holly F Walden, M Abdul Mottaleb

|Jun 27, 2024
N-Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H.

Dimitrios Moianos, Maria Makri, Georgia-Myrto Prifti

|Aug 23, 2023
Antiviral Evaluation of Dispirotripiperazines against Hepatitis B Virus.

Thane Jones, John E Tavis, Qilan Li

Pageof 3

Frequent Collaborators

4 joint publications

Grigoris Zoidis

2 joint publications

Ryan P Murelli

2 joint publications

Xinyong Liu

2 joint publications

Dongwei Kang